1-4 of 4
Zoltan Matrai, MD
Close
Sort by
Journal Articles

Spatial Convergent Clonal Evolution Leading to Ibrutinib Resistance and Disease Progression in Chronic Lymphocytic Leukemia

Richárd Kiss, Donát Alpár, PhD, Ambrus Gángó, MD, Noémi Nagy, Dora Aczel, Andras Matolcsy, MD PhD, Judit Csomor, Zoltán Mátrai, MD PhD, Csaba Bödör, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5539.
https://doi.org/10.1182/blood-2018-99-115937
Published: 2018
Journal Articles

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

Donát Alpár, PhD, Dóra Marosvári, MD, Richárd Kiss, Viktória Fésüs, Ambrus Gángó, MD, Noémi Nagy, Péter Farkas, MD, Szabolcs Tasnády, PhD, Marienn Réty, MD, Andras Matolcsy, MD PhD, Zoltán Mátrai, MD PhD, Csaba Bödör, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1457.
https://doi.org/10.1182/blood.V130.Suppl_1.1457.1457
Published: 2017
Journal Articles

Extramedullary Myeloid Sarcoma With Eosinophilia and FIP1L1-Pdgfra Rearrangement: Complete Cytogenetic Response To Imatinib Therapy

Zoltan Matrai, MD, PhD, Hajnalka Andrikovics, MD, PhD, Judit Csomor, MD, PhD, Botond Timár, MD, PhD, András Kozma, MD, Attila Tordai, MD, PhD, Tamas Masszi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5033.
https://doi.org/10.1182/blood.V122.21.5033.5033
Published: 2013
Journal Articles

Clinical Characteristics of JAK2 V617F Mutation Positive Acute Myeloid Leukemia.

Sarolta Nahajevszky, MD, Hajnalka Andrikovics, MD, Zoltan Matrai, MD, Nora Lovas, MD, Sandor Lueff, MD, Tamas Masszi, MD
Journal: Blood
Blood (2006) 108 (11): 4508.
https://doi.org/10.1182/blood.V108.11.4508.4508
Published: 2006